If you are taking aspirin in order to prevent heart attack or stroke, you probably are already aware of the down side. In-a-word, daily use of adult strength aspirin can lead to an increased risk of bleeding especially from the gastrointestinal or GI tract. This was recently underscored by University of Kentucky heart researchers:   

Is An Aspirin A Day Good For You?

ScienceDaily January 13, 2008

“Is an aspirin a day good for you, and how much should you take? Ten years after the FDA issued recommendations about the use of aspirin for people who have had heart attacks or are at risk for them, it may be a good time to talk to your doctor about the aspirin you're taking.”

"While aspirin is an effective drug for the prevention of clots," said Campbell, lead author of the report, "the downside of aspirin therapy is an increased tendency for bleeding (particularly from the GI tract). We believe the minimum effective dose should be utilized (75-81 mg)." However, Campbell notes, "We also believe more study in this area is warranted to determine if the minimum dose is effective for everyone, or if dose should be adjusted from person to person."

The goal of taking aspirin as a heart attack or stroke preventative lies in its power to prevent clots from forming in arteries. Aspirin pulls this off, in part, by increasingly platelet aggregation threshold. Platelets or thrombocytes are little disc shaped cells in everyone’s bloodstream that form blood clots. This clotting action keeps us from bleeding to death when we get a cut on a finger, toe or such. But, of course, clots can form and also block a major blood vessel. When this happens with respect to the heart, a heart attack occurs. When it happens with respect to blood flow to the brain, an ischemic stroke is the end result.

But what if you could take something natural that would lower the risk of clots forming like aspirin, but with a far lesser risk of bleeding from the GI tract or elsewhere? Does such a thing exist? It does. According to published studies, the herbal drug HEARTROL appears greatly reduce platelet aggregation threshold without any significant side-effects.   Consider:

A Scientifically Validated Tibetan Herbal "Drug" for Peripheral Arterial Occlusive Disease (PAOD) & More

Another study, headed by L. Samochowiec at the Pharmacological Institute of Szczecin, Poland and published in Herba Polonica (33:219-22. 1987) and Polbiopharm Reports (22:15-19, 1987), involved 100 patients with indisputably diagnosed peripheral arterial occlusive disease with intermittent claudication. The maximum average walking distance of the participants on a treadmill ergometer was less than 150 meters. After four months on HEARTROL, patients experienced a 98% increase in maximal walking distance; a statistically significant decrease in triglycerides and those lipid fractions (cholesterol components) involved in the genesis of artery-blocking plaque; and a 100% increase in platelet aggregation threshold (thus decreasing the likelihood that the disc-shaped platelets in the blood will stick together forming clumps that can attach to and/or suddenly block blood vessels).

In Switzerland, HEARTROL is approved as a drug for the treatment of peripheral arterial occlusive disease. Here in the USA it is sold as a dietary supplement.

If you are using aspirin to prevent heart attack or stroke, discuss the possibility of switching from it to HEARTROL with your primary care physician.

Also be sure to check out: CARDIUM and NUTRACENE

Disclaimer: The information contained in this article is provided for informational purposes only and should not be construed as medical advice or instruction. Readers are advised to consult a licensed health care professional concerning all matters related to their health and well being. Statements made and products sold through this web site have not been evaluated by the US Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease.